首页|选择性自噬受体对SLE患者Ⅰ型IFN过表达调节的研究进展

选择性自噬受体对SLE患者Ⅰ型IFN过表达调节的研究进展

扫码查看
系统性红斑狼疮(systemic lupus erythematosus,SLE)也被称为Ⅰ型IFN特征性疾病,是一种病因不明的慢性全身性自身免疫性疾病.体内过度免疫应答和Ⅰ型IFN的过量表达为该病的主要特征.在固有免疫应答过程中,核酸感受器对于病原体及体内核酸的过度反应是导致患者体内Ⅰ型IFN异常的主要原因之一.调节体内过度免疫反应及Ⅰ型IFN的过量表达对于缓解病情有重要作用.自噬作为调控机体稳态的重要过程可以抑制Ⅰ型IFN应答.该文就选择性自噬受体三方基序蛋白 21 (tripartite motif 21,TRIM21)、干扰素基因刺激物(stimulator of interferon gene,STING)、p62 通过介导多种信号通路中的关键调节因子的自噬来影响Ⅰ型IFN应答展开探讨.
Research progress on the regulation of type Ⅰ IFN overexpression by selective autophagy receptors in SLE patients
Systemic lupus erythematosus(SLE),also known as type Ⅰ IFN signature disease,is a chronic systemic autoimmune disease of unknown etiology.The main features of the disease are the overactive immune response and overexpression of type ⅠIFN.In the course of innate immune response,the overactive immune reaction of nucleic acid receptor to pathogen and nucleic acid in vivo is one of the reasons that lead to the type Ⅰ IFN abnormality in patients.Regulating the overactive immune response and the overexpression of type Ⅰ IFN play important roles in alleviating the disease.Autophagy,as an important process regula-ting body homeostasis,can inhibit the type Ⅰ IFN response.In this review,we discuss how the selective autophagic receptors tripartite motif 21(TRIM21),stimulator of interferon genes(STING),and p62 affect type Ⅰ IFN response by mediating auto-phagy of key regulators in multiple pathways.

systemic lupus erythematosustype Ⅰ interferonautophagic receptor

孙平、魏正萍、付萍

展开 >

昆明医科大学第二附属医院 风湿免疫科,昆明 650101

系统性红斑狼疮 Ⅰ型干扰素 自噬受体

国家自然科学基金昆明医科大学2022年研究生创新基金

818602872022S269

2024

现代免疫学
上海市免疫学研究所,上海市免疫学会

现代免疫学

CSTPCD
影响因子:0.4
ISSN:1001-2478
年,卷(期):2024.44(1)
  • 1